3 minute read
Nov. 28, 2022
A Selective CDK2 Inhibitor from Incyte
compound 5g
oral CDK2 Inhibitor oral/IV PK observed in rats in-house HTS and scaffold hopping ACS Med. Chem. Lett. Incyte Research Institute, Wilmington, DE
Loading...
oral CDK2 Inhibitor oral/IV PK observed in rats in-house HTS and scaffold hopping ACS Med. Chem. Lett. Incyte Research Institute, Wilmington, DE